Molecular Medicine (Feb 2023)

Role and mechanism of CD90+ fibroblasts in inflammatory diseases and malignant tumors

  • Feng Zeng,
  • Mengxiang Gao,
  • Shan Liao,
  • Zihua Zhou,
  • Gengqiu Luo,
  • Yanhong Zhou

DOI
https://doi.org/10.1186/s10020-023-00616-7
Journal volume & issue
Vol. 29, no. 1
pp. 1 – 13

Abstract

Read online

Abstract Fibroblasts are highly heterogeneous mesenchymal stromal cells, and different fibroblast subpopulations play different roles. A subpopulation of fibroblasts expressing CD90, a 25–37 kDa glycosylphosphatidylinositol anchored protein, plays a dominant role in the fibrotic and pro-inflammatory state. In this review, we focused on CD90+ fibroblasts, and their roles and possible mechanisms in disease processes. First, the main biological functions of CD90+ fibroblasts in inducing angiogenesis and maintaining tissue homeostasis are described. Second, the role and possible mechanism of CD90+ fibroblasts in inducing pulmonary fibrosis, inflammatory arthritis, inflammatory skin diseases, and scar formation are introduced, and we discuss how CD90+ cancer-associated fibroblasts might serve as promising cancer biomarkers. Finally, we propose future research directions related to CD90+ fibroblasts. This review will provide a theoretical basis for the diagnosis and treatment CD90+ fibroblast-related disease.

Keywords